Anna Marrs Sells 363 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 363 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $49.42, for a total transaction of $17,939.46. Following the transaction, the director owned 12,977 shares in the company, valued at $641,323.34. The trade was a 2.72% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anna Marrs also recently made the following trade(s):

• On Tuesday, June 2nd, Anna Marrs sold 365 shares of Docusign stock. The shares were sold at an average price of $55.04, for a total transaction of $20,089.60.

Docusign Trading Down 7.2%

Shares of Docusign stock opened at $47.26 on Friday. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $86.65. The firm has a market capitalization of $9.18 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 1.80 and a beta of 0.92. The firm’s 50 day simple moving average is $47.76 and its two-hundred day simple moving average is $54.16.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. Docusign had a net margin of 9.59% and a return on equity of 17.16%. Docusign’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.90 EPS. On average, sell-side analysts predict that Docusign Inc. will post 1.76 EPS for the current fiscal year.

Docusign announced that its board has authorized a share buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 21% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Institutional Trading of Docusign

Hedge funds have recently added to or reduced their stakes in the company. Nordea Investment Management AB boosted its holdings in Docusign by 3.8% during the fourth quarter. Nordea Investment Management AB now owns 1,198,634 shares of the company’s stock worth $82,502,000 after buying an additional 43,810 shares in the last quarter. Step Capital Management Pte. Ltd. purchased a new stake in Docusign during the fourth quarter worth $2,052,000. Retirement Systems of Alabama boosted its holdings in Docusign by 4.9% during the fourth quarter. Retirement Systems of Alabama now owns 544,473 shares of the company’s stock worth $37,242,000 after buying an additional 25,367 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Docusign by 11.1% during the third quarter. Envestnet Asset Management Inc. now owns 312,859 shares of the company’s stock worth $22,554,000 after buying an additional 31,334 shares in the last quarter. Finally, South Dakota Investment Council boosted its holdings in Docusign by 140.6% during the third quarter. South Dakota Investment Council now owns 53,373 shares of the company’s stock worth $3,848,000 after buying an additional 31,192 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on DOCU. Morgan Stanley cut their price objective on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 18th. Citigroup increased their price objective on shares of Docusign from $50.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday. Weiss Ratings upgraded shares of Docusign from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Bank of America began coverage on shares of Docusign in a research note on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price objective on the stock. Finally, Piper Sandler cut their price objective on shares of Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Docusign presently has an average rating of “Hold” and an average price target of $60.27.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign beat first-quarter expectations, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of $830.2 million versus $823.2 million estimated, with sales up 8.7% year over year. DocuSign Beats Fiscal Q1 Estimates, but IAM Traction Remains in Focus, RBC Says
• Positive Sentiment: The company said adoption of its AI-powered Intelligent Agreement Management platform is improving, and it raised full-year revenue guidance slightly, indicating demand remains healthy. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
• Neutral Sentiment: Analyst commentary remains mixed, with Wedbush lowering its price target to $58 from $60 while keeping a neutral rating, and BTIG cutting its target to $60 from $70 but maintaining a buy rating.
• Neutral Sentiment: DocuSign also highlighted AI integrations, including ChatGPT and Codex, and continued share repurchases, which support the long-term story but were not enough to offset near-term guidance concerns. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
• Negative Sentiment: Shares moved lower because the full-year outlook did not meaningfully exceed Wall Street expectations, dampening enthusiasm despite the earnings beat and prompting a “sell-the-news” reaction. DocuSign shares fall despite Q1 beat as guidance disappoints investors
• Negative Sentiment: Investors also appear to be focusing on whether DocuSign can accelerate growth beyond the low-double-digit range, as recent reports say the outlook “left investors looking for stronger signs of accelerating growth.” DocuSign stock falls as cautious outlook overshadows earnings beat

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.